Immunization therapy in Alzheimer's disease

Felix Mor*, Alon Monsonego

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

Original languageEnglish
Pages (from-to)653-659
Number of pages7
JournalExpert Review of Neurotherapeutics
Issue number5
StatePublished - 2006


  • Alzheimer's disease
  • Clinical trials
  • Meningoencephalitis
  • Th1/Th2 balance
  • Vaccination


Dive into the research topics of 'Immunization therapy in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this